UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) August 28, 2012
Cross Country Healthcare, Inc.
(Exact
name of registrant as specified in its charter)
Delaware | 0-33169 | 13-4066229 |
(State or Other Jurisdiction
of Incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification No.) |
6551 Park of Commerce Blvd., N.W., Boca Raton, FL 33487
(Address
of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s
telephone number, including area code)
Not Applicable
(Former
Name or Former Address, If Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
(a) On August 28, 2012, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing that it is scheduled to make a presentation at an upcoming investor conference. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.
Item 7.01 Regulation FD Disclosure.
Incorporated by reference is a press release issued by the Company on August 28, 2012, which is attached hereto as Exhibit 99.1. This information is being furnished under Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of such section.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit | Description | ||
99.1 |
Press Release issued by the Company on August 28, 2012 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
CROSS COUNTRY HEALTHCARE, INC. |
|||
|
By: |
/s/ Emil Hensel |
|
Name: |
Emil Hensel |
||
Title: |
Chief Financial Officer |
||
Dated: |
August 28, 2012 |
3
Exhibit 99.1
Cross Country Healthcare to Present at CL King Best Ideas Conference
BOCA RATON, Fla.--(BUSINESS WIRE)--August 28, 2012--Cross Country Healthcare, Inc. (Nasdaq:CCRN) announced today that it is scheduled to make a presentation on Thursday, September 13, 2012, at 10:40 a.m. Eastern Time at the CL King 10th Annual Best Ideas Conference being held at the Omni Berkshire Place Hotel in New York City.
Cross Country’s presentation will be webcast and accessible to the public online via the Company’s web site at www.crosscountryhealthcare.com. Replays will be available for 90 days after the presentation. Through this link, visitors will be able to access the Company’s presentation made by Joseph A. Boshart, Chief Executive Officer of Cross Country Healthcare, Inc., who will provide an overview of Cross Country’s business and prospects.
About Cross Country Healthcare
Cross Country Healthcare, Inc. is a diversified leader in healthcare staffing services offering a comprehensive suite of staffing and outsourcing services to the healthcare market that include nurse and allied staffing, physician staffing, clinical trial services and other human capital management services. The Company believes it is one of the top two providers of travel nurse and allied staffing services; one of the top four providers of temporary physician staffing (locum tenens) services; as well as a leading provider of clinical trial staffing services, retained physician search services and educational seminars specifically for the healthcare marketplace. On a company-wide basis, Cross Country Healthcare has approximately 4,100 contracts with hospitals and healthcare facilities, pharmaceutical and biotechnology customers, and other healthcare organizations to provide our healthcare staffing and outsourcing solutions. Copies of this and other news releases as well as additional information about Cross Country Healthcare can be obtained online at www.crosscountryhealthcare.com. Shareholders and prospective investors can also register at this website to automatically receive the Company's press releases, SEC filings and other notices by e-mail.
CONTACT:
Cross Country Healthcare, Inc.
Howard A. Goldman,
877-686-9779
Director/Investor & Corporate Relations
hgoldman@crosscountry.com
$E M2XNK=LG@.%<8_$CCUS7TV.E;UU9I>1E2U38N*PO$'ABS\07.D7-P2LVF7J7< M+J.25.2I]B0#]5%;M(3@5BG8T9X'\=="T_23I=[80FWFNY)OM&QVQ(1M(.,X M[GIZUZ@_P_\`"]_ID2_V/:VLK1#$]G&()%..NY,?7GBN!_:&YL?#_P#UUF_D ME:VO?%"^\/+9Z?1G&:UM)PC8RNE)W* MGPG\5:RWB?5_!^L73WS6`E,5PY+,/+D",I8\D$G(R>,8]*N^*_&.J:UXVA\# M>&+C[-*6Q?:@F"T2A=S!/0@=^N2`,=:UOAYX`@\*&YU.XOQJ6J7XW2W2CY=I M.X[3U.XX)/?`Z5YW\'W:Y^+NNSS@^ ZVY+H&J2CW/6;+X> M^%[>$+<:1;:A+@;[C48Q Y+/GD^V!7-^+_#EUX0TR;Q'X,FDLGLQYMSIX M8M;3Q`Y8^63A2!S\N.`< W.*_@7PUX?U_P=8ZMJ5I;:QJ M%Y'YES>7B"602'.Y0S9*[3D#;CIG`KBO@-;1:II7BG3KM-]I.D".@)&0PE#8 M]#@#D57N?!?CSX:7TU[X7N9;[3B=[)"N\D#L\7<^Z^_2MG!7<4[,S4G92/1] M*T74]%^(T40NKFXT`:5/]D64E_L[F:'=&7/)&`"NXY`R!P#6-I=S8^-_B?XA ML=;(GMM*(AL=-GP8GP2LDC)T 5;&>#GH>>@JE\0?ACJ6I:Z?$_A>[,.IY5I(?,,99E``9&'1L#G.`?7 MGF4K.T]!MZ7B:GCCP<;#P[>W/A%7TZ8QA;BSLDQ%<1Y&0(QPK@9(90">1SFO M1Q7A.D_%WQ%X8OUTKQOI WV-[;ZC8P7MI*LU MM.@DBD7HRD9!J)QE'1E1DGL6****@L****`"BBB@`HHHH`****`$- QQO8?B>/TK!NM0O+XYN;J67G(#-P#[#H*2TL+N_DV6MO)*>^T<#Z MGH*ZS3/`I+!]2GX_YY1'K]6_P_.H]Z1>B.1M;2XO9A#;0O+(?X5&?S]*[;1? M!<5N5GU+$L@Y$(^Z/KZ_R^M=-9V-K80B&UA2)/11U^I[U---'!&9)9%C11DL MQP!5J"6Y#E<5555"J,`<`#M5:_U*UTV`S74RQKV'=CZ`=ZYO5_&T$0:'3D\V M3D>:XP@^@ZGO^7>N6M[?4O$FH_?>:0_>D?[J#^GT%#GT0*/ 2D ($\:^'H6=D= M)[F*- 19-;N2BE\!O)W'"J`>"[<=>`"#SFIM&^#GA^+ M3HY-;274-7=O.GO!<2(?,/)VX(X![GGO6S=X+G^1DOB?*=I;>)M!O95BM-;T MZ>1CA4BND8D^P!KB?&'C.2_\06'A#PY)+<7LEU&U_/:,?]&A5QN!9>A]?0<' MK6Q=_"[PQJ"HM_#>W:I]U9[^9P/_`!ZN'T[0]6^''Q.TW3=*N6?P_K,QQ$Z@ M[=JDE3W!48((QD= H[@GZU3UWP!X/N4?4-=$SI$"3->:E,5C!ZX+/@ M#VJOH6I>%M)0/H2:]>6NSRE,$5Y=6Z@'^#=E.W5:+WBK;H+:N_4Y#X8>,KKP MYJDO@;Q0WV>6"0QVLDS8"'KY98G!4]5/OCN,,N;%_AK\81KEPC+H.KNZ-<'[ ML+2'<58]L.`>?X<]<&NSO=.\`_$/4PEVD=QJ5NA1H9#);7"KGHR':Y`]QQD] M,U)>7G@OP?:3Z3J * M1)8U=(P!5@<@CUKD/B7XFMO#_@Z\C+AKZ^C:UM(%/SN[C;D` Z2%3C)`##:OZ5MGP[X:\+O)K]S!/-<1J`U[= M&6\F0<\@G UUFY:& N:)JUKKNC6NIVC;H;A`P!ZJ>A4^A!!!'8@US$GCGP/XDLYK(W MC7\`*O+$EG._W6#`L`F<94=>/6J6GZIX$\2Z_(FBZU/!JET"[K9336OGD#EB MI`5VQWP3@>U.5Y:R6I*LMF87Q&T:SF^)W@]],A0:O/=K+'><`9Z[3QQT!7UK=TSPOH_A MZ>YU""&:6\E3]]=3R/<3NHYQEB6_`=<#CI7)SZ]\-I91ITER\-V+EYT"PW,= MPDTA+,RL%#J2>P(],8P*=^9 BS"Z-2BN.@^*7@VZN4MX-9$DTAV MI&MM,2Q]`-G-=9',LL*RIDHZAERI!P1GH>10TUN%T]B6BN0/Q.\(I>_8Y-5: M.ZW;/)>TG5]WIM*9S[5UJ.'0,,X/J,4FFMP33'4444#$-847A/3%NI;B='N) M)'+X<_*,G/0?US6[VKS75?$VKF_N8%NVCC25D41J%X!(Z]?UJ9-+<:39Z*BP MVT(50D<2C@`!5%9=WXIT>T#9NUE8?PP_/G\1Q^M>9SW,]T^^XGDE?^](Y8_K M47(Z<5#GV*Y#L+[QW,V5L;58Q_?F.X_D.!^9KF+S4;S4'WW=Q)*>V3P/H.@J MQIF@ZAJI!MX"(L\RO\JC_'\*[;2/"%CI^V6X_P!*N!R"XPJGV7_&E:4AZ1.8 MT/PK=:H5FGW6]KUW$?,X]A_7^=>A65A;Z=;+!:Q".,=AW/J?4U8X%9VJ:W9: M1'NN9AO(^6)>6;\/ZFM$E$AMLT68*,L0`.237':YXQ"DVND_O)"<&<#('LH[ MGWZ?6L/4]?U'Q!.+6)62)SA;>/DM_O'O_*NI\.>%X]+`N;L+)>$9'<1_3W]Z MGF EQ364,I4]",& MM$K$GS3\.KD^*/C2NJW*`M))/=A&Y"_*=H_X#D8^E?3`Z5\Q?#M#X4^,<.FW M\BHR3363.1@,Q!"8_P!XA45].#I6]?XEZ&5+9BU6N;*WNI+:2>%)'MI?-A M8CE'VE *VU\?BE\ M6Y+"\8OX?TG?+':9S'-L8*&;L=S,#_NC' CT['MGPB0+\+M&P.HE)_P"_KUVQKBOA$0?A?HN/[LH_\BO7;&L: MGQ,TC\*.4\$6EO;1Z\8(DC,FM73/M&,G+_``^&AO\`3]1O M3.(1ABB7 'UNQMCOH<)=P`_<;^\.<[3@XS[CM4MS;Q-\3 MM.F,:>8-(N<-CGB6`#_T)OS/K7E7B;3+[X2>.8?$>C1LVAWC[9+<9"J#RT1[ M#IN0]L8[<^G6.J6>M>,]%U&PF$MM<:+=/&P.>#-;\'T(Z$=B"* YI^#_#R^%_#-KI>Y'ECR\TB#`=V.2?4]<<]@*\K\<_\G`^&O\`MV_]&-7N M%>'^.?\`DX'PU_VZ_P#HQJ*3O)^C":LD>T7]E;ZE87%E=Q"6WN(S'(A_B4C! M%>)_%_2&T7X:^%M/F=9)K$I;&1>C8BP2/J5%>ZUY#^T%_P`BKI?_`%^_^R-1 M1;YT@J?"STS2U5O#U@C(K*UK&"I&01L&:\9^$9EL_BCXBTRP+C25\_,:_<&V M4+&?KC('J,U:\;:AXV\-^&])NUU8SZ'-'%'<_9+=898P0/EW_,5R.`XZ'KU` M/?\`P[L?#%OX6@NO"T&RUNANE=SF5G'!$A_O`YXZ#MP:=N6+?<-VO(\W^)6C MS^!/'%AXYTF%?(FGS/&.`)2"&'T=2W/KN]17LVF:O9ZOHUOJMK*#:3Q"57;C M`[Y]".<^A!I->T:U\0:)=Z5>J6M[F,HV.JGJ&'N"`1[BO#OA^=6BUG4_AI<3 M*;(7#/<2QL01$AQ(B=\2?*.V`6[FCXX^:_(7PRTZGJ/AC3H-7UV[\:3VRK)= MJ(-/W)ADM5Z/]9"2WJ%*CUKLJ9%$D421QHJ(@"JJC`4#H`*?63=S1*P4444A MA7D5Y!- 1P1/*_GO\L:EC]X]A7KAZ=ZS'UK1K$NC7EM&P)+*A!.>^0.]1 M))C3L<78>#-2NMK7&RUC/7> -]*B)$0GG]"J8!_P"^L']*Q[KQ[=."+6SBC_VI&+GZ]J7NHKWF=V%"J``` M!P`*S+_Q%IFF@B>Y4R`X\N/YFSZ8'3\<5YS>:YJ=^,7%[*R_W5.T?D,5GJ"Q M"J,D\`#FDY]@4.YU6I^-[JY#1V$?V9,XWMAG/]!^OUK#L=/OM;O"L(>60G,D MKDX'N36WH_@NYNRLNH$V\77R_P"-O\/QY]J[FSLK>P@6"VB6.->R_P`_ X72V*&A^'[71H 4CD^P]!6OTILDJ1(SR,$11DLQP`*XO6_&F0UOI M7T-P1_Z"/ZG_`.O5W2)LV=+>ZW:65W!:%M]S-(J"-3R,G&3Z"M$'-<7X:\-2 MO<)JFI;_`#,[XXV)W$_WF_P_/TKM::;8/0\R^)7PQ;Q+,FMZ+*+?6H0`?FVB M<#I\W\+CL?8`XP")O#OQ*-I!#IOC>TGT75$S'Y]S&5@N"/XE?[H]_P"'T/.* M[_[=;?;?L?FK]HV;_+[[?6FR7EJ+M+&1U\Z5=RQD?>'/^!_*K]I=69'+K=&+ M<>/O"EM#YC>(-.D]$AN%E=CZ*JY)/L!7'SQ^(_B!XLTN?[!<:3X9TN[2Y'VQ M=DMW(A!!V'D#L,]`2 VW/'#''W)5`*S_`/A)M%_Y_P"+]?\`"A24 M=@<6SSW6?"VI>#?'X\:>'[.2^L;@D:C8P+F4!R-[(/XLG#8'<>G*]K9>/?"U M[;B9==L(2 *2&-X2 MIB90R%>F#TQ4=Y?6VGP^;=2K%&3MW-TR>U'/I9!RZW9Y/\.?&$'@_3$\(^+4 M?2;NVD N'4$50FU/2=*E^SR2PV[$;M@7'7OP*)23=V@46M#& MTZZM?!GA<7/B._MK::>>6XN'9\)YTC-(43NV`2!@9.W.*Q_AYX]\/:O9S6,5 M_'%>OJ%W(EO,=CNLL\DB%0>O##(Z@@UVUEJ]AJ$C):7"RLHW$`'@>M375[;V M2HUS*(P[!%)[L>U+F5AV96UO1[+7M'N=,U"(26MPA5QW'H0>Q!P0>Q%>1_#' M0-4\*_%'4-"U"1W@M]/FDMFP0CH\L/SJ.V=HR/4'T->S7=Y;V-N9[J01Q`@% MB*D\N/S!+L7>`5#8Y`[C/X#\J<9M)Q$XW:9#?7]IIEI)=WUS#;6T8!>69PBK MS@9)X'-?/GC#Q7HUW\;-'U6WOXIK"S>W26XC.Y!AR201U`W AKWR]UK3M. M<)=7*1N1D)R6Q]!DU-9:C::C&7M+A)57@[3R/J.U$)J+"4>8BTS6=.UJV:YT MR^MKR!7V-);R!U#8!P2.^"#CW%>+_'3Q1H^IZ9IVFV&HVUU<1W#R2K#('\O` MVX)'0Y)XZ\&O=JJVFIV=^9!:W"2F/&_;VST_D:(2Y97"4>96.;\/:UX<\8^% M[?2X[RTO!+8(+BT\P%T7:%.Y N0&7C/'^SCZ#/2LIO$FCI(R-?Q!E)4CG@_E352UT]F)PN5[/QIX P":VE66,]&4YJ*]U2RTX(;RX6$/G;NSSCK_,4H MS44_,;BVT6()H[FWCGAD62*10Z.AR&!Y!![BI*S[36M.OIQ!;7:22D9"C.<5 MH5)04444`(>E>0:F"=5O#@_Z]_\`T(U[!2=*F4;C3L>+8/H:='#+-((XHG=S MT5%))KVBBI]F5SGG>G>";ZZ`>\86L?\`=^\Y_`<#\_PKL=,T'3]*4&W@'FXP M97Y8_CV_"M.BJ44B7)L.!6#JWBJPT[='&WVFF*8D%[!XXT];Z[6YD,#$,L83`P M_&!^/YUUH@B$OF^6GF8QOQSCTS08(C,)C&AD`P'*C(_&IY1W$N/^/>7_`'#_ M`"K@]$O98=(AC76;"WP6_=RQ99?F/6O0",U6.G6/_/G;_P#?I?\`"AJX7'VD M@ELH9%D20,@.]?NM[CVKDM9N&U7Q!]D%K/=V=D#YJ1#.7(/\O?T-=DB(D81% M55`P`HP!38X(H2QCC1-QRVU0,GWH:!,YSP?>R^1-I=T&2XM3D*_#;#[>W]11 MXZP-!4]_.7^1KHQ;Q+*91&@E(P7"C./K1+#%,NV6-)%SG#J"*+:6"^MRE9ZU MIU[.(+6[CDDP3M7.<"JGBY5_X1F\.T9^3G'^VM:L5G;0MNBMXHV]40`U)+%' M,A25%=#U5AD&G;014TA0-'LB``3;ID_\!%8_C0,;&R"MM8W:`'&<'!YKI$54 M0(H`51@`#``ILL$4VWS8T?: :G'/"&4%%@"'/U% M=MV-,EABG39+&CKG.UAD5(!@4)! A/3C M:/PK5TF\TN[U6[;3[9MX'[VY5<(YXX'/)_#L:U;BSMKM56Y@BF"G*B1`V/SI M\4,<*!(D5$'15``%)*P7,GQ-J3V&ELD.3 N]>WADD61XT9U.59E!*_3TI98(IUVRQI(O MHRY%#3;!,?C(KA-)_M1++4YM/%NZQW+DQR(69B`,XQ[=J[O'%,CABB!$:*@) MR=JXR?PIM7!.QA^#HH$T(/#-YIED+R?*!M;@$8_#]:H^,7\N]T=A*D1$Q(=Q MD+RO)]A751010`B*)(P3DA%`R?PI);:"<`30QR`=-Z@X_.E;2P7,'2+]YM05 M)-7L;G